SAMBATARO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 1.523
AS - Asia 708
EU - Europa 303
SA - Sud America 189
AF - Africa 11
OC - Oceania 1
Totale 2.735
Nazione #
US - Stati Uniti d'America 1.494
SG - Singapore 300
HK - Hong Kong 174
BR - Brasile 146
IT - Italia 108
VN - Vietnam 100
CN - Cina 63
DE - Germania 57
FR - Francia 42
IE - Irlanda 24
AR - Argentina 23
CA - Canada 20
AT - Austria 17
GB - Regno Unito 16
BD - Bangladesh 15
ID - Indonesia 12
FI - Finlandia 10
EC - Ecuador 9
NL - Olanda 8
TR - Turchia 8
IN - India 7
MX - Messico 7
ZA - Sudafrica 6
CL - Cile 5
IQ - Iraq 5
RU - Federazione Russa 5
AZ - Azerbaigian 4
JP - Giappone 3
MA - Marocco 3
PL - Polonia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
ES - Italia 2
IL - Israele 2
PK - Pakistan 2
PY - Paraguay 2
SE - Svezia 2
UA - Ucraina 2
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
SA - Arabia Saudita 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.735
Città #
Dallas 1.205
Hong Kong 173
Singapore 116
San Jose 80
Ho Chi Minh City 50
Ashburn 46
The Dalles 33
Dublin 24
Beijing 19
Milan 16
Naples 15
Santa Clara 15
São Paulo 15
Hanoi 11
Frankfurt am Main 10
Catania 9
Helsinki 8
Montreal 8
Boardman 7
Istanbul 7
Munich 7
Rio de Janeiro 7
Düsseldorf 6
Los Angeles 6
New York 6
Biên Hòa 5
Brasília 5
Misilmeri 5
Nuremberg 5
Vienna 5
Assago 4
Baku 4
Boston 4
Brooklyn 4
Curitiba 4
Haiphong 4
Palermo 4
Porto Alegre 4
Quito 4
Triggiano 4
Amsterdam 3
Baghdad 3
Campinas 3
Casoria 3
Chennai 3
Dhaka 3
Durban 3
Ealing 3
Guayaquil 3
Manchester 3
Mexico City 3
Ribeirão Preto 3
Rome 3
San Francisco 3
Seattle 3
Tashkent 3
Varallo Pombia 3
Warsaw 3
Abbotsford 2
Avellino 2
Bandung 2
Belo Horizonte 2
Bologna 2
Buenos Aires 2
Chicago 2
Corato 2
Da Nang 2
Duque de Caxias 2
Fortaleza 2
General Roca 2
Guarulhos 2
Hortolândia 2
Hải Dương 2
Ijuí 2
Independencia 2
Isidro Casanova 2
Johannesburg 2
Joinville 2
Kyiv 2
Lauterbourg 2
London 2
Machala 2
Manaus 2
Miami 2
Moscow 2
Osaka 2
Phủ Lý 2
Piritiba 2
Portsmouth 2
Quảng Ngãi 2
Resistencia 2
Salvador 2
San Giorgio del Sannio 2
Santiago 2
Santo André 2
Secaucus 2
Stockholm 2
São José 2
Thái Nguyên 2
Três Lagoas 2
Totale 2.102
Nome #
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report and Literature Review 273
Neurocrine tumors of the lung [I TUMORI NEUROENDOCRINI DEL POLMONE] 253
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 220
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study 184
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 75
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 73
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 67
Nonpegylated liposome-encapsulated doxorubicin (NPLED) and cyclophosphamide in the treatment of platinum-resistant ovarian cancer: Final results of a phase II study 64
Brain Metastasis in Endometrial Cancer: A Systematic Review 62
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 55
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 50
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 48
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 48
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 47
IL-6-174 G>C and MMP-9-1562 C>T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients 47
Chemotherapy extravasation: diagnosis, prevention and management 46
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 46
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 46
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 45
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 45
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 42
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 42
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 42
Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante 41
LONG-TERM CANCER SURVIVORS: CONCERNS AND UPDATES 41
[Second-line chemotherapy and new drugs for ovarian carcinoma] 40
A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features 39
Prognostic Factors for Adrenocortical Carcinoma Outcomes 39
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial 38
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network 38
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study 36
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer 36
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial 35
Effectiveness of low molecular weight heparin (LMWH) in cancer-related disseminated intravascular coagulation (DIC). A case report 35
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 34
Bronchial carcinoid associated to Cushing syndrome|IL CARCINOIDE BRONCHIALE ASSOCIATO A SINDROME DI CUSHING 30
Bronchial carcinoid associated with Cushing's syndrome 28
The immune system response during development and progression of carcinogen-induced rat mammary tumors: prevention of tumor growth and restoration of immune system responsiveness by thymopentin 25
The pathology of medullary carcinoma of the thyroid: Review of the literature and personal experience on 62 cases 25
Exploratory Analysis of Dunning–Kruger Effect Among Oncologists Managing Prostatic Adenocarcinoma Candidates for Radionuclide Therapy 20
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 19
Il deficit cognitivo nei pazienti oncologici in trattamento antiblastico. 15
Pegylated liposomial doxorubicin with escalating dose vinorelbina in metastatic breast carcinoma: a dose finding study. 13
Oxaliplatin (L-OHP), folinic and fluorouracil (5FU) for advanced breast cancer (BC) patients (pts) refractary to anthracyclines (ant) and taxanes (tax). 12
Escalating Doses of gemcitabine in combination with cisplatin in advanced urothelial carcinoma: a dose finding study. 12
Melanoma Sliding Doors 2022 Management and targeted treatment for melanoma BRAF+ patients 11
Follow up of colorectal cancer 11
Utilità di un follow up accurato nel trattamento delle metastasi polmonari ed epatiche da carcinoma colo-rettale: descrizione di due casi clinici. 10
ATHENA (GOG-3020/ENGOT-ov45): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study of the Poly (ADP-Ribose) Polymerase (PARP) Inhibitor Rucaparib + the PD-1 Inhibitor Nivolumab Following Frontline Platinum-Based Chemotherapy in Ovarian Cancer 10
Study on the perception of memory and concentration deficit of patients undergoing antiblastic therapy. 10
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department 10
Retrospective study about treatment protocol of an advanced colorectal carcinoma by 5fluouracil double modulation by leucovorin and interferon. 9
Adjuvant treatment of colo-rectal cancer with combined chemotherapy and radiation therapy 9
Importanza di una adeguata terapia nutrizionale di supporto nel paziente neoplastico in fase avanzata: l’esperienza di un day hospital oncologico. 9
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience 9
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival 9
Escalating Doses of Paclitaxel in combination with Epirubicin and Cisplatin in Advanced Ovarian Epithelial Carcinoma: A Dose Finding Study. 9
Doppia modulazione del 5 FU con Leucovorin ed Interferon * nel carcinoma colorettale in stadio avanzato. Risultati di uno studio clinico. 9
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. 9
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG 8
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente 8
Trombosi e Cancro 8
Tossicità dell’associazione RT-CT nel carcinoma del retto: valutazione della fattibilità in rapporto al regime citostatico adottato 8
Il sistema immunitario durante la progressione tumorale: approccio sperimentale e clinico 8
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES 8
Melanoma Setting Next Horizon 2023. Mnagement and targeted treatment for melanoma BRAF+ Patients. 8
Nutritional Status, Inflammatory Parameters and Cancer 7
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 7
Effetto dell’interleuchina 2 sulla mucosite indotta da trattamento citostatico con 5 fluorouracile ad alte dosi in infusione continua e acido folinico in pazienti con adenocarcinoma del colon retto in stadio avanzato. 7
Il trattamento del carcinoma gastrico localmente avanzato e metastatico in regime di day hospital: possibilità di applicazione dell’infusione continua (ECF) 7
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) 7
Terapia adiuvante e qualità di vita: tossicità del trattamento con folati e 5-FU a scopo precauzionale e sue implicazioni cliniche 7
Neoadjuvant chemotherapy followed by surgery in patients with squamous cell cervical carcinoma 7
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. 7
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. 6
Chemotherapy for transitional cell carcinoma (TCC) patients (pts) unsuitable to cisplatinum: a phase II study of gemcitabine (G) and vinorelbine (V) combination. 6
Tumor markers in the diagnosis, prognosis, and follow-up of colorectal cancer: CEA, CA 19-9 and TPA 6
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial 6
The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems 6
Metronomic shedule of Capecitabine in poor performance status Patients (PTS) with pretreated solid tumors 6
Gemcitabine (G) as a six-hour infusion in patients (pts) with metastatic, largely treated, solid tumours. 6
Descrizione e valutazione di alcuni casi di metastasi epatiche da carcinomi del grosso intestino trattate con terapia citostatica e successiva resezione 6
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. 6
Phase II study of irinotecan and fluorouracil/leucovorin (FOLFIRI) in patients with primary advanced gastric cancer. Preliminary results 5
MITO-11 - A randomized multicenter phase II trial testing the addition of pazopanib to weekly paclitaxel in platinum resistant or refractory advanced ovarian cancer (AOC) 5
Tromboembolismo in oncologia medica 5
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice 5
Valutazione di CEA, TPA E CA 15.3 nel follow-up del carcinoma della mammella e nel monitoraggio della risposta alla terapia nella fase avanzata. 5
Neuroimmunomodulation in Neoplasia: Role of Cytokines and Thimic Hormones 5
Beyond BRCA: preliminary results of a study for the implementation of hereditary cancer diagnoses. 4
Determinazione della Triiodiotironina con tecniche immunochimiche non radioisotopiche Determination of Triiodiothyronine by non radioisotopic techniques 4
Toxicity From Monoimmunotherapy In Patients Aged =80 Years: Our Experience 4
Totale 2.913
Categoria #
all - tutte 9.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20245 0 0 0 0 0 0 0 0 0 0 0 5
2024/2025610 12 5 9 2 18 96 68 44 69 121 84 82
2025/20262.298 103 282 1.122 256 230 221 84 0 0 0 0 0
Totale 2.913